Skip to main content
. 2022 Jul 16;13:321. doi: 10.1186/s13287-022-02972-3

Table 2.

Side effects of severe COVID-19 patients received hUC-MSCs

Patient number Liver function Urea Cr Blood routine ECG Tumor marker# Thrombotic/embolic Impaired vision Analysis
ALT AST
P1 25 37 4.96 60 Normal Normal Norma Normal Normal
P2 29 23 6.14 82 Normal Normal CA12-5 elevated* Normal Normal Aged patient
P3 33 39 3.92 77 Normal Normal Normal Normal Normal
P4 15 18 3.44 57 Normal Normal Normal Normal Normal
P5 11 34 3.50 50 Normal Normal NSE elevated* Normal Normal Slightly elevated
P6 15 10 3.14 55 Normal Normal Normal Normal Normal
P7 34 29 4.21 83 Normal Normal Normal Normal Normal
P8 20 26 5.11 61 Normal Normal Normal Normal Normal

Normal range: ALT 9-50U/L; AST 15-40U/L; Urea 1.7–8.3 mmol/L; Cr 40–80 umol/L; CA12-5: 0–35 U/ml; NSE: 0–16.3 ng/ml

ECG Electrocardiogram, ALT alanine aminotransferase, AST aspartate aminotransferase, Cr creatinine

# Tumor marker includes: CEA, CA12-5, CA19-9, SCC, NSE, AFP, PSA (for males)

*CA12-5: 53 U/ml; NSE:18.5 ng/ml